Trial Profile
A Single-Arm, Open-Label Study of the Safety and Reduction of Signs and Symptoms During Treatment With Tocilizumab in Combination With Methotrexate, in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Methotrexate; Methotrexate
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Sponsors Roche
- 11 Mar 2013 Planned end date changed from 1 Feb 2013 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 03 Jan 2013 Planned End Date changed from 1 Dec 2012 to 1 Feb 2013 as reported by ClinicalTrials.gov.
- 10 Aug 2012 Actual patient number changed from 424 to 436 as reported by ClinicalTrials.gov.